Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Rang in aandelen #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Aandeelprijs
$0.1559364
Laatst gesynchroniseerd: 2026-09-18
Marktkapitalisatie
$195.17K
Verandering (1 dag)
6.60%
Verandering (1 jaar)
-30.91%
Land
GB
Handel Fusion Antibodies plc (FAB)

Categorie

Winst voor Fusion Antibodies plc (FAB)
Winst in Sep 2025 TTM: $-2.06M
Volgens de meest recente financiële verslagen van Fusion Antibodies plc bedraagt de huidige winst van het bedrijf $-2.06M. In 2024 behaalde het bedrijf een winst van $-2.89M, een stijging ten opzichte van de winst van 2023, die $-3.53M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Fusion Antibodies plc van 2013 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-2.06M -10.23%
2025 $-2.30M -20.56%
2024 $-2.89M -18.12%
2023 $-3.53M 101.40%
2022 $-1.75M 0.58%
2021 $-1.74M 30.88%
2020 $-1.33M -31.84%
2019 $-1.95M 95.89%
2018 $-997.05K -731.20%
2017 $157.96K 304.33%
2016 $39.07K -126.49%
2015 $-147.46K -26.55%
2014 $-200.78K -72.11%
2013 $-719.78K 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$5.27B -256,061.35%
US
$1.95B -94,754.12%
NL
$-3.09B 149,694.82%
US
$-4.02B 194,783.51%
AU
- -
CH